Literature DB >> 2077346

Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction.

M Leinonen1, E Linnanmäki, K Mattila, M S Nieminen, V Valtonen, M Leirisalo-Repo, P Saikku.   

Abstract

The presence of circulating immune complexes (IC) was studied using two detection methods specific for chlamydial lipopolysaccharide (LPS) in paired serum samples of 44 patients (30 men and 14 women) with acute myocardial infarction (AMI). Forty-four random controls were individually matched for locality, age and sex with the AMI patients. As specificity controls for the IC assays single serum samples from 29 patients with diseases characterized by the presence of circulating IC were used. Fifty-seven per cent of AMI patients, 12% of their random controls and 10% of the patient controls were shown to have chlamydial LPS-specific immune complexes in their sera (P less than 0.0001, AMI versus random and patient controls). This finding provides further evidence of the possible association of chronic chlamydial infection with AMI.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2077346     DOI: 10.1016/0882-4010(90)90042-o

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  19 in total

1.  Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography.

Authors:  M Smieja; S Chong; M Natarajan; A Petrich; L Rainen; J B Mahony
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.

Authors:  T Hohlfeld; P Klemm; C Thiemermann; T D Warner; K Schrör; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection.

Authors:  Y Fan; S Wang; X Yang
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

Authors:  F Blasi; F Denti; M Erba; R Cosentini; R Raccanelli; A Rinaldi; L Fagetti; G Esposito; U Ruberti; L Allegra
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

Review 6.  Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis.

Authors:  S J Bourke; N F Lightfoot
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

7.  Chlamydia pneumoniae in atheroma: consideration of criteria for causality.

Authors:  A Shor; J I Phillips; G Ong; B J Thomas; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

8.  Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice.

Authors:  E Blessing; T M Lin; L A Campbell; M E Rosenfeld; D Lloyd; C Kuo
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

9.  Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.

Authors:  Anil Palikhe; Marja-Liisa Lokki; Pekka Saikku; Maija Leinonen; Mika Paldanius; Mikko Seppänen; Ville Valtonen; Markku S Nieminen; Juha Sinisalo
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

10.  Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro.

Authors:  H M Surcel; H Syrjälä; M Leinonen; P Saikku; E Herva
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.